| Health / Medical Topics |
Renal Cell Carcinoma Peptides Vaccine IMA901
A multipeptide cancer vaccine targeting renal cell carcinoma with potential immunopotentiating activity. Renal cell carcinoma peptides vaccine IMA901 consists of 10 different synthetic tumor-associated peptide (TUMAP) antigens (9 HLA-class I-binding and 1 HLA class II-binding); endogenously, these TUMAPs are expressed by the majority of renal cell carcinomas. Vaccination with this agent may significantly increase host cytotoxic T-lymphocyte (CTL) immune responses against tumor cells expressing these peptide antigens. (NCI Thesaurus)
YOU MAY ALSO LIKE
Renal cell carcinoma (RCC) is a heterogeneous term comprising a group of neoplasms of renal origin. There are 4 major histologic subtypes…
A term that refers to the staging of renal cell carcinoma according to the American Joint Committee on Cancer, 7th edition. …
A group of kidney carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2. These translocations result in the…
Renal cell carcinoma that develops in patients who are long-term survivors of childhood neuroblastoma.
The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules…
The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules…
